Paradigm Biopharmaceuticals Limited (ASX:PAR): Is Breakeven Near?
We feel now is a pretty good time to analyse Paradigm Biopharmaceuticals Limited’s ( ASX:PAR ) business as it…
We feel now is a pretty good time to analyse Paradigm Biopharmaceuticals Limited’s ( ASX:PAR ) business as it…
Rogers Communications Inc. has declared invalid an attempt by Edward Rogers to replace five members of the company’s board…
Emails showed Theranos’ former senior product manager was told to change reference ranges to make test results seem normal…
Cian PLC filed an F-1 statement, intending to list ADSs on NYSE under the ticker symbol CIAN. The company’s…
It’s clear analysts are very reluctant to get too bullish about 2022.
This ad technology stock bucked the industry trend.